Modern Scientific Concepts and Clinical Consequences of LONG COVID Syndrome, Especially In Relation to its Impact on Cardiovascular Diseases
Keywords:
post-covid syndrome, hypertension, cardiovascular diseasesAbstract
Modern scientific data confirm that post-covid syndrome (LONG COVID) has a significant impact on the cardiovascular system, especially increasing the risk of hypertension, myocarditis, thrombosis, and endothelial dysfunction. Studies show that patients who have had COVID-19 exhibit renin-angiotensin-aldosterone system (RAAS) regulation disorders, which can contribute to the development of hypertension even in previously healthy individuals. Also, persistent changes in the expression of microRNA involved in inflammatory and fibrotic processes have been identified, which can accelerate the progression of cardiovascular diseases [1]. Additionally, autonomic nervous system dysfunction, accompanied by increased sympathetic nervous system activity, can also play a role in post-covid hypertension. Clinical consequences include an increased risk of stroke, heart attack, and heart failure.
In therapeutic practice, it is recommended to pay attention to long-term monitoring of blood pressure, correction of inflammatory processes, and maintenance of endothelial health [2].
References
Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult COVID-19 patients in Wuhan, China: a retrospective cohort study // The Lancet. 2020. Vol. 395, No. 10229. P. 1054-1062.
Gupta A., Madhavan M. V., Sehgal K., et al. Extrapulmonary manifestations of COVID-19 // Nature Medicine. 2020. Vol. 26. P. 1017-1032.
Sattar N., McInnes I. B., McMurray J. J. V. Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms // Circulation. 2020. Vol. 142. No. 1. P. 4-6.
Libby P., Luscher T. COVID-19 is, in the end, an endoteliac disease // European Heart Journal. 2020. Vol. 41, No. 32. P. 3038-3044.
Wenzel P., Kopp S., Göbel S., et al. Evidence of SARS-CoV-2 mRNA in endoteliy and myocardium in COVID-19 patients // European Heart Journal. 2020. Vol. 41, No. 32. P. 3108-3119.
Nishiga M., Wang D. W., Han Y., Lewis D. B., Wu J. C. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives // Nature Reviews Cardiology. 2020. Vol. 17, No. 9. P. 543-558.
Varga Z., Flammer A. J., Steiger P., et al. Endothelial cell infection and endotheliitis in COVID-19 // The Lancet. 2020. Vol. 395, No. 10234. P. 1417-1418.
Oxley T. J., Mocco J., Majidi S., et al. Large-vascular stroke as a presenting feature of COVID-19 in the young // New England Journal of Medicine. 2020. Vol. 382, No. 20. P. e60.
Wichmann D., Sperhake J. P., Lütgehetmann M., et al. Autopsy findings and venous thromboembolism in patients with COVID-19 // Annals of Internal Medicine. 2020. Vol. 173, No. 4. P. 268-277.
Long B., Brady W. J., Koyfman A., Gottlieb M. Cardiovascular complications in COVID-19 // The American Journal of Emergency Medicine. 2020. Vol. 38, No. 7. P. 1504-1507.
Pons S., Fodil S., Azoulay E., Darmon M. The vascular endoteliy: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection // Critical Care. 2020. Vol. 24. No. 1. P. 353.
Ackermann M., Verleden S. E., Kuehnel M., et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19 // New England Journal of Medicine. 2020. Vol. 383, No. 2. P. 120-128.
Giustino G., Croft L. B., Stefanini G. G., et al. Characterization of myocardial injury in patients with COVID-19 // Journal of the American College of Cardiology. 2020. Vol. 76, No. 18. P. 2043-2055.
Li H., Liu L., Zhang D., et al. SARS-CoV-2 and viral sepsis: observations and hypotheses // The Lancet. 2020. Vol. 395, No. 10235. P. 1517-1520.
McGonagle D., Bridgewood C., Meaney J. F. M. A tripartmental model of lung, bone marrow, and endothelial damage in COVID-19 // The Lancet Rheumatology. 2020. Vol. 2, No. 9. P. e465-e473.
Clerkin K. J., Fried J. A., Raikhelkar J., et al. COVID-19 and cardiovascular disease // Circulation. 2020. Vol. 141, No. 20. P. 1648-1655.
Mahmud E., Dauerman H. L., Welt F. G. P., et al. Management of acute myocardial infarction during the COVID-19 pandemic // Journal of the American College of Cardiology. 2020. Vol. 76, No. 11. P. 1375-1384.
Lippi G., Lavie C. J., Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis // Progress in Cardiovascular Diseases. 2020. Vol. 63, No. 3. P. 390-391.
Ranucci M., Ballotta A., Di Dedda U., et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome // Journal of Thrombosis and Haemostasis. 2020. Vol. 18, No. 7. P. 1747-1751.
Xiong T. Y., Redwood S., Prendergast B., Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications // European Heart Journal. 2020. Vol. 41, No. 19. P. 1798-1800.
